immunohistochemical data (Human Protein Atlas)
86
Structured Review
Human Protein Atlas
immunohistochemical data
Immunohistochemical Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+data/data+immunohistochemistry/pmc13264208-473-1-15
Average 86 stars, based on 1 article reviews
Immunohistochemical Data, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ihc+data/data+immunohistochemistry/pmc13264208-473-1-15
Average 86 stars, based on 1 article reviews
immunohistochemical data - by Bioz Stars,
2026-09
86/100 stars
Images
1) Product Images from "ExIR enables prioritizing driver and biomarker genes from omics data in a reference free manner"
Article Title: ExIR enables prioritizing driver and biomarker genes from omics data in a reference free manner
Journal: iScience
doi: 10.1016/j.isci.2026.116303
Figure Legend Snippet: Differential immunoreactivity of known and novel ExIR-predicted LUAD biomarkers between normal and cancer samples (A–E) Immunohistochemical (IHC) data from the Human Protein Atlas database in LUAD and normal lung tissue for top five known LUAD biomarkers. (A) SFTPC–ExIR rank #1, LUAD (negative intensity; patient ID: 1847) and normal pneumocytes (quantity: 75%–25%; strong intensity; patient ID: 2268). (B) SPP1—ExIR rank #117, LUAD (quantity: >75%; moderate intensity; patient ID: 537) and normal pneumocytes (not detected; patient ID: 2268). (C) CBLC—ExIR rank #140, LUAD (quantity: >75%; moderate intensity; patient ID: 1847) and normal pneumocytes (not detected; patient ID: 2417). (D) MDK—ExIR rank #247, LUAD (quantity: 75%–25%; strong intensity; patient ID: 1847) and normal pneumocytes (not detected; patient ID: 2222). (E) MRC1 – ExIR rank #471, LUAD (undetected; patient ID: 1932) and normal macrophages (quantity: 75%–25%; strong intensity; patient ID: 2208). (F–I) IHC data of top five ExIR-predicted LUAD biomarkers (excluding SFTPC rank #1 already in a). (F) AGER – ExIR rank #2, LUAD (not detected; patient ID: 3144) and normal pneumocytes (quantity: >75%; strong intensity; patient ID: 4840). (G) EMP2 – ExIR rank #3, LUAD (not detected; patient ID: 1847) and normal pneumocytes (quantity: >75%; strong intensity; patient ID: 2101). (H) CAV1 – ExIR rank #4, LUAD (not detected; patient ID: 1249) and normal pneumocytes (quantity: >75%; strong intensity; patient ID: 2208). i, RTKN2 – ExIR rank 5, LUAD (not detected; patient ID: 3003) and normal pneumocytes (quantity: <25%; moderate intensity; patient ID: 2268).(J–N) IHC data of top six ExIR-predicted LUAD up-regulated biomarkers (excluding FAM83A rank #2, for which no IHC data was available). (J) PYCR1 – ExIR rank #1, LUAD (quantity: >75%; moderate intensity; patient ID: 2777) and normal pneumocytes (not detected; patient ID: 2208). (K) TOP2A – ExIR rank #3, LUAD (quantity: 75%–25%; strong intensity; patient ID: 3003) and normal pneumocytes (quantity: 75%–25%; weak intensity; patient ID: 2101). (L) MMP11 – ExIR rank #4, LUAD (quantity: >75%; weak intensity; patient ID: 1847) and normal pneumocytes (not detected; patient ID: 2438). (M) TEDC2– ExIR rank 5, LUAD (quantity: 75%–25%; moderate intensity; patient ID: 4208) and normal pneumocytes (not detected; patient ID: 1470). (N) IQGAP3– ExIR rank 6, LUAD (quantity: >75%; strong intensity; patient ID: 3048) and normal pneumocytes (not detected; patient ID: 1470). Per the Human Protein Atlas database usage guidelines, the link to the immunostaining images of all of the selected proteins in normal pneumocytes and LUAD samples are included as hyperlinks within the figure legend. Ab: antibody; LUAD: lung adenocarcinoma.
Techniques Used: Immunohistochemical staining, Immunostaining
Related Articles
Immunohistochemistry:Article Title: IGF2R as a master regulator of acquired EGFR inhibitor resistance and therapeutic target in non-small cell lung cancer. Article Snippet: Non-small cell lung cancer (NSCLC), a leading cause of cancer-related mortality worldwide, often develops resistance to targeted therapies, limiting long-term treatment success.. Although agents such as the EGFR inhibitor osimertinib and the marine-derived small molecular compound Debromoaplysiatoxin (DAT), which we have demonstrated to markedly inhibit EGFR signaling in our preliminary data, show efficacy in advanced NSCLC, acquired resistance remains a major clinical challenge.. This study identifies insulin-like growth factor 2 receptor (IGF2R) as a key mediator of acquired resistance to both osimertinib and DAT. Article Title: Pan-Cancer Analysis of NOP2 Reveals Its Prognostic Relevance and Association With the Tumor Immune Microenvironment Article Snippet: .. In addition, Article Title: High-fat diet reshapes microbial interactions to promote breast cancer stemness via Streptococcus mutans-induced leucine accumulation. Article Snippet: .. However, Article Title: PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP78 Article Snippet: .. Analyses of Article Title: USP48 promotes tumour progression through the deubiquitination and stabilization of DBF4 in clear cell renal carcinoma. Article Snippet: .. USP48 expression was assessed using Article Title: Integrative Multiomics and Single‐Cell Analyses Identify FKBP10 as a Predictor of Radiotherapy Outcome in Colorectal Cancer Article Snippet: .. Supporting the clinical relevance of our transcriptomics findings, publicly available Article Title: Vascular SMC-like CAF-derived THBS1 drives tumor-associated neutrophil recruitment to orchestrate an immunosuppressive microenvironment in gastric cancer. Article Snippet: .. Consistently, Article Title: Targeting XIAP-coordinated PKC signaling resensitizes PD-1-refractory tumors for rechallenge. Article Snippet: .. Expressing:Article Title: Pan-Cancer Analysis of NOP2 Reveals Its Prognostic Relevance and Association With the Tumor Immune Microenvironment Article Snippet: .. In addition, Article Title: High-fat diet reshapes microbial interactions to promote breast cancer stemness via Streptococcus mutans-induced leucine accumulation. Article Snippet: .. However, Article Title: USP48 promotes tumour progression through the deubiquitination and stabilization of DBF4 in clear cell renal carcinoma. Article Snippet: .. USP48 expression was assessed using Article Title: Vascular SMC-like CAF-derived THBS1 drives tumor-associated neutrophil recruitment to orchestrate an immunosuppressive microenvironment in gastric cancer. Article Snippet: .. Consistently, Staining:Article Title: PRAS40 activates the IRE1α-XBP-1-mediated unfolded protein response to exacerbate colorectal cancer by enhancing ST6Gal1-dependent α-2, 6 sialylation of GRP78 Article Snippet: .. Analyses of Article Title: Integrative Multiomics and Single‐Cell Analyses Identify FKBP10 as a Predictor of Radiotherapy Outcome in Colorectal Cancer Article Snippet: .. Supporting the clinical relevance of our transcriptomics findings, publicly available Transcriptomics:Article Title: Integrative Multiomics and Single‐Cell Analyses Identify FKBP10 as a Predictor of Radiotherapy Outcome in Colorectal Cancer Article Snippet: .. Supporting the clinical relevance of our transcriptomics findings, publicly available |
